The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Полное описание

Библиографические подробности
Главные авторы:	Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Формат:	Статья
Язык:	English
Опубликовано:	BMC 2025-01-01
Серии:	BMC Complementary Medicine and Therapies
Предметы:	Mild cognitive impairment Alzheimer’s disease Cannabidiol Cannabis-based medicine Patient engagement Patient and public involvement
Online-ссылка:	https://doi.org/10.1186/s12906-025-04753-w

Схожие документы

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
по: Ana Pilar Pérez-Acevedo, и др.
Опубликовано: (2020-12-01)

Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study)
по: Elmar Graessel, и др.
Опубликовано: (2024-10-01)

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
по: Anna Gościniak, и др.
Опубликовано: (2024-11-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
по: Zackary Montoya, и др.
Опубликовано: (2020-09-01)

El cannabidiol y sus indicaciones en psiquiatría
по: Juan Fernando Muñoz Ramírez
Опубликовано: (2021-03-01)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences
по: Anna Stasiłowicz-Krzemień, и др.
Опубликовано: (2023-09-01)

Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia
по: Klara Spiegl, и др.
Опубликовано: (2021-09-01)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
по: Kelsey Meyer, и др.
Опубликовано: (2022-01-01)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
по: Davide Fortin, и др.
Опубликовано: (2021-10-01)

Cannabidiol use and perceptions in France: a national survey
по: Clémence Casanova, и др.
Опубликовано: (2022-08-01)

Pharmacovigilance on cannabidiol as an antiepileptic agent
по: Ilaria Ammendolia, и др.
Опубликовано: (2023-02-01)

Patterns of cannabidiol use among marijuana users in the United States
по: Ji-Yeun Park
Опубликовано: (2025-02-01)

The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT
по: Toni Marie Rudisill, MS, PhD, и др.
Опубликовано: (2023-03-01)

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
по: Milena de Barros Viana, и др.
Опубликовано: (2022-11-01)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
по: Masashi Kitamura, и др.
Опубликовано: (2020-09-01)

Effects of Cannabidiol on Locomotor Activity
по: Fabrizio Calapai, и др.
Опубликовано: (2022-04-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
по: Donovan A. Argueta, и др.
Опубликовано: (2020-04-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
по: Qianru Rao, и др.
Опубликовано: (2022-11-01)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
по: Zuzanna Lubczyńska, и др.
Опубликовано: (2023-06-01)

In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract
по: Paweł Śledziński, и др.
Опубликовано: (2023-12-01)

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs
по: Sasithorn Limsuwan, и др.
Опубликовано: (2024-04-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L.
по: Laura Daniela Martinenghi, и др.
Опубликовано: (2020-06-01)

Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers
по: Marco Antonio Zenone, и др.
Опубликовано: (2021-07-01)

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
по: Schilling JM, и др.
Опубликовано: (2021-05-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
по: Francesco Paolo Busardò, и др.
Опубликовано: (2021-01-01)

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
по: Tangui Barré, и др.
Опубликовано: (2024-01-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
по: Diana E. Sepulveda, и др.
Опубликовано: (2022-10-01)

Total cannabidiol (CBD) concentrations and yields from traditional extraction methods: Percolation vs. maceration
по: Jason Wilson, и др.
Опубликовано: (2022-10-01)

Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
по: Gniewko Wieckiewicz, и др.
Опубликовано: (2022-03-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
по: Swapnali Chetia, и др.
Опубликовано: (2020-08-01)

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
по: Zsolt Gáll, и др.
Опубликовано: (2020-05-01)

Cannabis Effects on Driving Performance: Clinical Considerations
по: Brianna Costales, и др.
Опубликовано: (2023-01-01)

Production of Cannabidiol Acid Synthase by Chassis Pichia pastoris and of Its Catalytic Activity Analysis
по: Tingli NIU, и др.
Опубликовано: (2023-10-01)

What are the informational pathways that shape people’s use of cannabidiol for medical purposes?
по: Marco A. Zenone, и др.
Опубликовано: (2021-05-01)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
по: Anjali K. Bhardwaj, и др.
Опубликовано: (2024-03-01)

The Potential of Cannabidiol for Treating Canine Atopic Dermatitis
по: Ana F. Bizarro, и др.
Опубликовано: (2025-02-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
по: John S. Markowitz, и др.
Опубликовано: (2022-11-01)

Safety assessment of female sexual hygiene product containing cannabidiol in new zealand white rabbit and clinical trial
по: Atiwut Kamudhamas, и др.
Опубликовано: (2024-12-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
по: José A. Crippa, и др.
Опубликовано: (2018-09-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
по: Luisa Rocha, и др.
Опубликовано: (2020-03-01)